Diebold Nixdorf (DBD) Tops Q1 EPS by 9c, Revenues Beat; Offers FY21 Revenues Outlook
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $68.59 -1.59%
Financial Fact:
Income (loss) from discontinued operations: 0.01
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Income (loss) from discontinued operations: 0.01
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q1 EPS of $0.29, $0.09 better than the analyst estimate of $0.20. Revenue for the quarter came in at $943.9 million versus the consensus estimate of $941.22 million.
GUIDANCE:
Diebold Nixdorf sees FY2021 revenue of $4-4.1 billion, versus the consensus of $4.09 billion.
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Halozyme adds biotech executive Appelhans to its board
- 374Water Inc (SCWO) Misses Q2 EPS by 15c
Create E-mail Alert Related Categories
Corporate News, Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
